REGISTRATION OBTAINED FOR AIRING™ IN UKRAINE
In the first quarter of 2024 marketing authorization was obtained in Ukraine for Airing™.
REGISTRATION OBTAINED FOR AIRING™ IN CROATIA, BULGARIA, AND ROMANIA
In the last quarter of 2023 marketing authorizations were obtained in Croatia, Romania, Bulgaria for Airing™.
REGISTRATION OBTAINED FOR AIVIAL™ IN BULGARIA AND MOLDOVA
Aivial has been licensed from Mithra (Belgium).
SUCCESSFULL PHARMACOVIGILANCE AUDIT
We are developing a product portfolio of both affordable generics and new chemical entities/dosage forms with an emphasis on women’s health.
Aicore Life Sciences receives exclusive licenses from Mithra for commercialization of Myring™ (Airing™) and Tibelia® (Aivial™)
Aicore Life Sciences receives exclusive licenses from Mithra.
BACTERIAL VAGINOSIS: FURTHER UPDATE ON THE DEVELOPMENT OF AICORE LIFE SCIENCES’ NEW PRODUCT
The development of Aicore Life Sciences’ new product
Update on the development stages of Aicore Life Sciences’ new treatment for bacterial vaginosis
This new product will be indicated for the treatment of bacterial vaginosis.
AICORE LIFE SCIENCES SIGNS AGREEMENT WITH THE UNIVERSITY OF GHENT
The first step of cooperation will be a clinical trial (“proof of concept”) to be performed under ALS’s supervision and financed 50/50 by ALS and the University of Ghent
Launch of Aicore Life Sciences
A Letter of the Internet was signed to establish the incorporation of a new pharmaceutical company.